235 related articles for article (PubMed ID: 30309339)
1. Successful resolution of coats disease by photodynamic therapy: a case report.
Namba M; Shiode Y; Morizane Y; Kimura S; Hosokawa M; Doi S; Toshima S; Takahashi K; Hosogi M; Fujiwara A; Shiraga F
BMC Ophthalmol; 2018 Oct; 18(1):264. PubMed ID: 30309339
[TBL] [Abstract][Full Text] [Related]
2. Combined photodynamic therapy and intravitreal bevacizumab injection for the treatment of adult Coats' disease: a case report.
Kim J; Park KH; Woo SJ
Korean J Ophthalmol; 2010 Dec; 24(6):374-6. PubMed ID: 21165239
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment for Coats' disease: retinal laser photocoagulation combined with intravitreal bevacizumab injection was effective in two cases.
Kodama A; Sugioka K; Kusaka S; Matsumoto C; Shimomura Y
BMC Ophthalmol; 2014 Mar; 14():36. PubMed ID: 24666524
[TBL] [Abstract][Full Text] [Related]
4. Resolution of exudative retinal detachment and regression of retinal macrocyst post-laser in Coats disease.
Munira Y; Zunaina E; Azhany Y
Int Med Case Rep J; 2013; 6():37-9. PubMed ID: 23966803
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal dexamethasone implant with retinal photocoagulation for adult-onset Coats' disease.
Kumar K; Raj P; Chandnani N; Agarwal A
Int Ophthalmol; 2019 Feb; 39(2):465-470. PubMed ID: 29380183
[TBL] [Abstract][Full Text] [Related]
6. The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.
Li S; Deng G; Liu J; Ma Y; Lu H
BMC Ophthalmol; 2017 May; 17(1):76. PubMed ID: 28532448
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
Ramasubramanian A; Shields CL
Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
[TBL] [Abstract][Full Text] [Related]
8. Coats-like Exudative Vitreoretinopathy in Retinitis Pigmentosa: Ocular Manifestations and Treatment Outcomes.
Moinuddin O; Sathrasala S; Jayasundera KT; Branham KH; Chang EY; Qian CX; Recchia FM; Fahim AT; Besirli CG
Ophthalmol Retina; 2021 Jan; 5(1):86-96. PubMed ID: 32507488
[TBL] [Abstract][Full Text] [Related]
9. INTRAVITREAL RANIBIZUMAB INJECTION AND RETINAL LASER PHOTOCOAGULATION TREATMENT FOR ADULT-ONSET COATS DISEASE.
Plaza-Laguardia C; Pascual-Camps I; Bayón-Porras MR; Sánchez-Cañizal J; Gallego-Pinazo R
Retin Cases Brief Rep; 2021 Sep; 15(5):532-535. PubMed ID: 31913217
[TBL] [Abstract][Full Text] [Related]
10. The follow-up observation on the therapeutic effect of photodynamic therapy for the juxtapapillary retinal capillary hemangioma: a case report.
Tong B; Xiao J; Su G
BMC Ophthalmol; 2018 Oct; 18(1):277. PubMed ID: 30367611
[TBL] [Abstract][Full Text] [Related]
11. [Adjuvant anti-VEGF therapy in Coats' disease].
Fiorentzis M; Stavridis E; Seitz B; Viestenz A
Ophthalmologe; 2015 May; 112(5):451-4. PubMed ID: 25134462
[TBL] [Abstract][Full Text] [Related]
12. Secondary Coats' response to retinal vasculitis managed with bevacizumab.
Chaudhary P; Varshney A; Videkar C
Indian J Ophthalmol; 2018 Sep; 66(9):1355-1357. PubMed ID: 30127171
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study.
Gao T; Qu J; Xiao J; Hu J; Zhao M
Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1429-1439. PubMed ID: 29869216
[TBL] [Abstract][Full Text] [Related]
14. Rhegmatogenous retinal detachment in Coats' disease: a case report.
Khadka S; Byanju R; Parajuli S
J Med Case Rep; 2021 Dec; 15(1):631. PubMed ID: 34969406
[TBL] [Abstract][Full Text] [Related]
15. Fluorescein Angiographic Abnormalities in the Contralateral Eye with Normal Fundus in Children with Unilateral Coats' Disease.
Jung EH; Kim JH; Kim SJ; Yu YS
Korean J Ophthalmol; 2018 Feb; 32(1):65-69. PubMed ID: 29376220
[TBL] [Abstract][Full Text] [Related]
16. Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center.
Shields CL; Udyaver S; Dalvin LA; Lim LS; Atalay HT; L Khoo CT; Mazloumi M; Shields JA
Indian J Ophthalmol; 2019 Jun; 67(6):772-783. PubMed ID: 31124485
[TBL] [Abstract][Full Text] [Related]
17. Early onset coats' disease initially treated as unilateral ROP at 39 weeks postmenstrual age: a case report.
Peng J; Zhang Q; Chen C; Huang Q; Li Y; Zhao P
BMC Ophthalmol; 2017 Aug; 17(1):145. PubMed ID: 28814287
[TBL] [Abstract][Full Text] [Related]
18. Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture.
Shields JA; Shields CL; Honavar SG; Demirci H
Am J Ophthalmol; 2001 May; 131(5):561-71. PubMed ID: 11336930
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy in von Hippel-Lindau disease in children.
Fortunato M; Di Pietro R; Gravina L; Maggi R; Ubaldi A; Vadalà P
J Pediatr Ophthalmol Strabismus; 2009; 46(6):376-9. PubMed ID: 19928746
[TBL] [Abstract][Full Text] [Related]
20. Selective photocoagulation in Coats' disease: ten-year follow-up.
Nucci P; Bandello F; Serafino M; Wilson ME
Eur J Ophthalmol; 2002; 12(6):501-5. PubMed ID: 12510719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
